Keros Therapeutics

$53.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.22 (+2.32%) Today
$0.00 (0.00%) As of 6:00 PM EDT after-hours

Why Robinhood?

You can buy or sell KROS and other stocks, options, and ETFs commission-free!

About KROS

Keros Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on treatments for rare muscle diseases. Read More The company was founded in 2015 and is headquartered in Lexington, MA. The listed name for KROS is Keros Therapeutics, Inc. Common Stock.

Employees
23
Headquarters
Lexington, Massachusetts
Founded
2015
Market Cap
1.09B
Price-Earnings Ratio
Dividend Yield
Average Volume
91.00K
High Today
$54.58
Low Today
$52.03
Open Price
$53.17
Volume
42.44K
52 Week High
$65.50
52 Week Low
$19.10

Collections

KROS Earnings

-$5.11
-$3.41
-$1.70
$0.00
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 12, Pre-Market

You May Also Like